DOT spectacle lenses
Commercial- Indications
- Myopia, Myopia progression in children
Company intelligence / Profile preview
SightGlass Vision
Palo Alto, California, United Statessightglassvision.com ↗
- Ownership
- Private
- Employees
- ~26
- Development stage
- Commercial
01
Overview
The company’s DOT spectacle lenses have demonstrated statistically significant efficacy and safety for slowing myopia progression in children aged 6–10 years. The pivotal CYPRESS study showed superiority over control lenses at multiple time points up to four years, with positive results for both axial length and refractive error outcomes. The technology has received FDA Breakthrough Device Designation and has been launched commercially in China, the Netherlands, Israel, and other regions.
- Therapeutic areas
- Ophthalmology
- Modalities
- Device (spectacle lens)Non-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
CooperCompaniesEssilorLuxottica
Beyond the preview
Go deeper on SightGlass Vision.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SightGlass Vision.